Direxion Daily Healthcare Bull 3x Shares (CURE)
| Assets | $153.87M |
| Expense Ratio | 0.93% |
| PE Ratio | 21.48 |
| Shares Out | 2.05M |
| Dividend (ttm) | $1.08 |
| Dividend Yield | 1.40% |
| Ex-Dividend Date | Sep 23, 2025 |
| Payout Ratio | 29.97% |
| 1-Year Return | -40.57% |
| Volume | 125,582 |
| Open | 76.50 |
| Previous Close | 75.13 |
| Day's Range | 75.91 - 77.49 |
| 52-Week Low | 66.00 |
| 52-Week High | 134.62 |
| Beta | 1.91 |
| Holdings | 68 |
| Inception Date | Jun 15, 2011 |
About CURE
Fund Home PageThe Direxion Daily Healthcare Bull 3x Shares (CURE) is an exchange-traded fund that is based on the S&P Health Care Select Sector index. The fund provides 3x levered exposure to a market cap weighted sub-index of the S&P 500 that tracks the performance of US listed health care companies. CURE was launched on Jun 15, 2011 and is issued by Direxion.
Top 10 Holdings
65.98% of assets| Name | Symbol | Weight |
|---|---|---|
| Goldman Sachs FS Treasury Intms Instl | n/a | 15.09% |
| Dreyfus Govt Cash Man Ins | n/a | 10.95% |
| Eli Lilly and Company | LLY | 8.78% |
| Johnson & Johnson | JNJ | 6.29% |
| AbbVie Inc. | ABBV | 5.82% |
| Health Care Select Sector Index Swap | n/a | 5.31% |
| UnitedHealth Group Incorporated | UNH | 4.66% |
| Abbott Laboratories | ABT | 3.50% |
| Merck & Co., Inc. | MRK | 2.95% |
| Thermo Fisher Scientific Inc. | TMO | 2.62% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 23, 2025 | $0.31013 | Sep 30, 2025 |
| Jun 24, 2025 | $0.30549 | Jul 1, 2025 |
| Mar 25, 2025 | $0.34549 | Apr 1, 2025 |
| Dec 23, 2024 | $0.116 | Dec 31, 2024 |
| Sep 24, 2024 | $0.33292 | Oct 1, 2024 |
| Jun 25, 2024 | $0.27294 | Jul 2, 2024 |
News
Direxion's Ultra-Leveraged CURE ETF Offers An Opportunity To Play The Potential Valuation Reset
Amid rising concerns about stagflation, investors have continued to bid up the equities sector. As evidence, the benchmark S&P 500 sector is up over 13% year-to-date.
Healthcare Sector Could Be on the Comeback Trail
Large-cap momentum names have been pushing the healthcare sector aside. Investors have primarily been flocking to Magnificent Seven names benefiting from the artificial intelligence (AI) push.
CURE: Adding Defensive Exposure Amid Frothy Market Valuations
The Direxion Daily Healthcare Bull 3X Shares ETF tracks an index composed of U.S. healthcare stocks. While the healthcare sector as a whole is essentially flat in 2025, the effect of beta slippage and...
Top Performing Leveraged/Inverse ETFs: 08/17/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
CURE: Make an Adventurous Bet on an Undervalued Sector
The healthcare sector, the fifth-largest sector exposure in the S&P 500, was once a reliable destination for investors who wanted dependable performance without taking on significant risk. The group h...
Top Performing Leveraged/Inverse ETFs: 07/27/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
CURE: A Useful Speculative Tool But Not An Investing Hold
CURE is designed for daily 3x leveraged exposure to the healthcare sector, making it suitable for short-term speculation or hedging, not long-term investment. Daily resets and derivatives costs cause ...
CURE: Analyst Estimates Point To Significant Gains In 2025
The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% (3x) of the return of an index focused on large-cap US healthcare stocks. Since October 2024 the forward P/E ratio for CURE's lar...
CURE: A Leveraged ETF To Own Throughout This Century
The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% of the performance of an index heavily concentrated in large-capitalization US healthcare stocks. CURE's top ten holdings trade a...
JD Henning Cautious About 2024, An Unusual Year For Market Considerations
JD Henning discusses his approach to the market and emphasizes the importance of timing and using momentum gauges to avoid major market downturns. Investing vs trading portfolios.
Healthcare Dashboard, And The Side Effects Of CURE
Pharmaceuticals/biotechnology and life science tools are close to their historical baseline in value and quality. Healthcare equipment is the most overvalued subsector. Ten healthcare stocks cheaper t...
July Breakout ETF/ETNs Week 29 - 2023: Strongest Momentum Gainers For Next Week
This article highlights current and future ETF/ETN breakouts for Week 29 using the MDA momentum cycle model. Following the positive Momentum Gauge signal on June 1st, leading funds include NAIL +67.1%...
CURE: One Of Those Rare 3x Leveraged ETFs That Has Delivered Long-Term Returns
IXVTR has been one of the best-performing healthcare indices. Investments in a 3x leveraged ETF benchmarking IXVTR can thus provide attractive returns. CURE has been one of those rare 3x leveraged ETF...
Direxion Daily Healthcare Bull 3x Shares: The CURE / S&P 500 Divergence Is A Tell
Launched in June 2011, CURE has a long track record for a leveraged ETF. What makes this 3x leveraged ETF truly unique is its shockingly high multi-year returns.
Hedge Forecast Price Ranges For CURE, Healthcare ETFs And Stocks
Risk-avoidance for Market-Makers required in filling volume “block trade” market orders, these hedging-derived prices are not just single-point “targets”. Their highs and lows are expected limits, ref...
Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch
The Direxion Daily Healthcare Bull 3X Shares (NYSE: CURE) gapped up almost 2.52% higher on Monday in response to outbreaks of monkeypox being reported in several western nations. CURE is a triple leve...
CURE: One Of The Best Performing 3X Shares ETF
CURE is one of those rare 3x ETFs which generated positive returns under every scenario.
Direxion Daily Healthcare Bull 3X Shares Provides Magnified Returns With A Healthcare Focus
Direxion Daily Healthcare Bull 3X Shares is a triple leveraged bullish healthcare-focused index.
Biotech Innovations Remain At Forefront
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...
Healthcare: A Wide Choice Of Large And Well-Established Companies
The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...
Direxion Leveraged Healthcare ETF Ready To Make House Calls In 2021
Coronavirus vaccines are being distributed, but case counts continue rising, a pair of scenarios ensuring the healthcare center will again be an epicenter of activity in 2021. What Happened Healthcare...
Healthcare Sector Is Gonna Get Exciting, Capture That With CURE
The healthcare sector is shaking off rust accrued earlier this year and with the 2020 election season mostly behind the group – pending next month's Georgia Senate runoff elections – market observers ...
A CURE For The Common Earnings Play
It has the potential to be lost in this week's earnings hubbub, which is dominated by growth-ier communication services and technology stocks, but don't sleep on reports from blue-chip healthcare stoc...
3 Leveraged Healthcare ETFs Soaring This Month
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidem...